These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 11858799

  • 21. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK, Dhir A.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703
    [Abstract] [Full Text] [Related]

  • 22. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
    Andreasen JT, Redrobe JP.
    Behav Brain Res; 2009 Jan 30; 197(1):150-6. PubMed ID: 18786574
    [Abstract] [Full Text] [Related]

  • 23. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J, Schmidt WJ.
    Behav Brain Res; 2004 May 05; 151(1-2):191-9. PubMed ID: 15084435
    [Abstract] [Full Text] [Related]

  • 24. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.
    Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi RW, Samanin R.
    Br J Pharmacol; 1999 Nov 05; 128(6):1332-8. PubMed ID: 10578149
    [Abstract] [Full Text] [Related]

  • 25. Monoamine involvement in the antidepressant-like effect induced by P2 blockade.
    Diniz CRAF, Rodrigues M, Casarotto PC, Pereira VS, Crestani CC, Joca SRL.
    Brain Res; 2017 Dec 01; 1676():19-27. PubMed ID: 28916441
    [Abstract] [Full Text] [Related]

  • 26. Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat.
    Esposito E, Ossowska G, Samanin R.
    Eur J Pharmacol; 1987 Apr 29; 136(3):429-32. PubMed ID: 3111866
    [Abstract] [Full Text] [Related]

  • 27. Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test.
    Flores-Serrano AG, Vila-Luna ML, Álvarez-Cervera FJ, Heredia-López FJ, Góngora-Alfaro JL, Pineda JC.
    Pharmacol Biochem Behav; 2013 Sep 29; 110():89-97. PubMed ID: 23769836
    [Abstract] [Full Text] [Related]

  • 28. Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.
    Furmaga H, Shah A, Frazer A.
    Biol Psychiatry; 2011 Nov 15; 70(10):937-45. PubMed ID: 21907323
    [Abstract] [Full Text] [Related]

  • 29. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.
    Szot P, Franklin A, Miguelez C, Wang Y, Vidaurrazaga I, Ugedo L, Sikkema C, Wilkinson CW, Raskind MA.
    Neuropharmacology; 2016 Feb 15; 101():76-86. PubMed ID: 26362360
    [Abstract] [Full Text] [Related]

  • 30. Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.
    Sherwin E, Lennon A, Harkin A.
    Int J Neuropsychopharmacol; 2017 Oct 01; 20(10):833-843. PubMed ID: 28977524
    [Abstract] [Full Text] [Related]

  • 31. Modulation of MK-801-induced behaviour by noradrenergic agents in mice.
    Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE.
    Psychopharmacology (Berl); 2001 Mar 01; 154(2):177-88. PubMed ID: 11314680
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors.
    Einat H, Clenet F, Shaldubina A, Belmaker RH, Bourin M.
    Behav Brain Res; 2001 Jan 08; 118(1):77-83. PubMed ID: 11163636
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment.
    Harro J, Häidkind R, Harro M, Modiri AR, Gillberg PG, Pähkla R, Matto V, Oreland L.
    Eur Neuropsychopharmacol; 1999 Dec 08; 10(1):5-16. PubMed ID: 10647090
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
    Harro J, Jossan SS, Oreland L.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct 08; 346(4):425-31. PubMed ID: 1436127
    [Abstract] [Full Text] [Related]

  • 40. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
    De Bundel D, Femenía T, DuPont CM, Konradsson-Geuken Å, Feltmann K, Schilström B, Lindskog M.
    Int J Neuropsychopharmacol; 2013 Oct 08; 16(9):2041-51. PubMed ID: 23672849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.